Popular Articles
Cellulite Cream

Sebelius: Single-Payer Health Care Not In Plans
In an interview with NPR, Health and Human Services Secretary Kathleen Sebelius stressed that talk of a public plan doesn"t mean that a single-payer option is a possibility. "This is not a trick. This is not single payerò€¦ That"s not what anyone is talking about - mostly because the president feels strongly, as I do, that dismantling private health coverage for the 180 million Americans that have it, discouraging more employers from coming into the marketplace, is really the bad, you know, is a bad direction to go," she said. Sebelius added that a public insurance option would pressure private insurance companies to lower costs, which she says is "a good thing for the American public. Medicare right now has lower overhead than private insurers." Some Republicans have argued that Americans currently in private plans would flee to the public option, but Sebelius countered that expanding health insurance would potentially create "50 million-plus new insurance customers, whether you"re talking about a private plan or public option."
generic viagra online
Mersana Reports Preliminary Phase 1 Results Of XMT-1001 In Patients With Advanced Solid Tumors
Mersana Therapeutics presented preliminary results of a Phase 1 clinical trial for its lead development candidate, XMT-1001, in a poster session at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando. XMT-1001 is a broad-spectrum cytotoxic, based on camptothecin (CPT), conjugated to Mersana"s biodegradable polymer platform, Fleximer(R).
News of the day
Study Offers First Look At Effects Of Genetic Copy Number Variation On Volatile Anesthetics
A study published in the July issue of Anesthesiology offers perhaps the first estimation of how genomic copy number variation (CNV) can influence anesthetic sensitivity and the magnitude of this influence.
Diagnostics

Manchester Clinical Psychologist Wins May Davidson Award, UK

Dr Sam Cartwright-Hatton from the University of Manchester has won this year"s May Davidson Award. The award is made each year by the British Psychological Society"s Division of Clinical Psychology to someone who has made an outstanding contribution to the development of clinical psychology within the first 10 years of their career. Dr Cartwright-Hatton is a senior lecturer in the School of Psychological Sciences at the University of Manchester and her research has concentrated on anxiety disorders in childhood. She has recently completed a four-year Medical Research Council clinician scientist fellowship during which she tested a new parenting-based intervention for young anxious children, a group who have been neglected by previous treatment approaches. Dr Cartwright-Hatton says: "I am delighted to receive the May Davidson Award, which has many previous winners whose work I greatly admire. I take it as recognition of the importance of treating anxiety disorders in childhood. Not only do they cause considerable distress to children and families in themselves, they are known to be linked with problems like depression and substance misuse later in life." As part of her award Dr Cartwright-Hatton will give a lecture at the Division"s Annual Conference. This will take place at the Congress Centre, 28 Great Russell Street, London WC1, on 9-11 December 2009. Further details of the event can be found on the conference website: www.dcpconference.co.uk. The May Davidson Award is made by the Division of Clinical Psychology each year to a clinical psychologist who has made a significant contribution to the profession within 10 years of qualifying. May Davidson was a pioneer of clinical psychology in the early days of the National Health Service and died in 1982. British Psychological Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):